Skip to main content
Juan Alderuccio, MD, Hematology, Miami, FL, UMHC-Sylvester Comprehensive Cancer Center

JuanPabloAlderuccioMD

Hematology • Miami, FL

Hematologic Oncology

Associate Professor, Lymphoma Program, Division of Hematology, Sylvester Comprehensive Cancer Center

Join to view full profile

Dr. Alderuccio is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Alderuccio's full profile

Already have an account?

Summary

  • I am a board-certified Hematologist-Oncologist, and I specialize in the treatment of patients diagnosed with lymphoma. I also conduct clinical research focused on expanding the treatment repertoire for patients diagnosed with various lymphomas.

    My research efforts are geared toward improving and expanding the treatment options available for patients diagnosed with both aggressive and indolent lymphomas. In particular, I am interested in the development of novel, targeted therapies which hinges on the use of genetic sequencing technology. My current research is aimed at identifying clinical characteristics in patients with marginal zone lymphoma in an attempt to distinguish those prone to a worse outcome, as well as a higher risk for transformation to an aggressive lymphoma. Furthermore, I am also involved in studies integrating PET/CT data in the risk stratification of lymphoma patients, with the goal of developing strategies for individualize care.

Education & Training

  • University of Miami/Jackson Health System
    University of Miami/Jackson Health SystemFellowship, Hematology and Medical Oncology, 2014 - 2017
  • New York Medical College (Metropolitan)
    New York Medical College (Metropolitan)Residency, Internal Medicine, 2011 - 2014

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2017 - 2025
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Clinical Investigator Career Development Award Lymphoma Research Foundation, 2022
  • FDA-AACR Oncology Educational Fellowship FDA and AACR, 2021-2022
  • K12 Calabresi Clinical Oncology Research Career Development Award NCI, 2019-2021

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • The Evaluation and Treatment (Tx) of Burkitt Lymphoma (BL) in the Modern Era: Real World (RW) Outcomes and Prognostication across 26 US Cancer Centers (CC)
    Juan Pablo Alderuccio, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Splenic Marginal Zone Lymphoma: A U.S Population-Based Survival Analysis (1997-2016)
    Juan Pablo Alderuccio, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Outcomes of Patients with Newly-Diagnosed Burkitt Lymphoma (BL) and Central Nervous System (CNS) Involvement Treated in the Modern Era: A Multi-Institutional Real-Worl...
    Juan Pablo Alderuccio, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Lectures

  • Omission of Staging Bone Marrow Biopsy Does Not Affect Outcomes in Patients with Stage I Extranodal Marginal Zone Lymphoma (EMZL) Treated with Radiation Therapy 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • R-MACLO-IVAM Is an Effective Regimen to Induce Long Term Remission in Untreated Mantle Cell Lymphoma 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Revised-MALT-IPI: A New Predictive Model That Identifies High-Risk Patients with Extranodal Marginal Zone Lymphoma (EMZL) 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Join now to see all

Press Mentions

  • BostonGene and Sylvester Comprehensive Cancer Center at the University of Miami Announce Collaboration
    BostonGene and Sylvester Comprehensive Cancer Center at the University of Miami Announce CollaborationMay 23rd, 2023
  • Third-Line BTK Inhibitor Combo Doubles PFS in Follicular Lymphoma
    Third-Line BTK Inhibitor Combo Doubles PFS in Follicular LymphomaJune 5th, 2022
  • ADC Therapeutics Announces Abstracts to Be Presented at the 63rd ASH Annual Meeting
    ADC Therapeutics Announces Abstracts to Be Presented at the 63rd ASH Annual MeetingNovember 4th, 2021
  • Join now to see all

Committees

  • Member, Protocol Review and Monitoring Committee 2021 - Present
  • Member, American Society of Hematology Committee on Educational Affairs

Professional Memberships

Other Languages

  • Spanish

Hospital Affiliations

Dr. Juan Alderuccio, Dr. Juan Alderuccio, MD, Dr. J Alderuccio, Dr. Juan Pablo Alderuccio